Experiment 735455

Worktypes

PHARMACOLOGY OF COMPOUND - IN VIVO

Compounds isolated

COMBRETASTATIN A-4

Alerts

DATA INCOMPLETE - DERIVED FROM AN ABSTRACT.

Details

PropertyValue
Pharmacology
ANTIANGIOGENIC ACTIVITY
Administration routeIP
OrganismEmpty organism
CitationNABHA,SM: MOHAMMAD,RM: WALL,NR: DUTCHER,JA: SALKINI,BM: PETTIT,GR: AL-KATIB,AM:. (2001). EVALUATION OF COMBRETASTATIN A-4 PRODRUG IN A NON-HODGKIN'S LYMPHOMA XENOGRAFT MODEL: PRECLINICAL EFFICACY.. 12(1)
Amount utilized
Compound isolated
DiseaseVS.WSU-CL2-SCID MOUSE MODEL.
Dose amount800.0 MG
Number2
Qualitative resultACTIVE
AnimalMOUSE
Per unitKG
Dose expressionDOSE
GenderFEMALE